SymBio Pharmaceuticals

Edison Investment Research is terminating coverage on SymBio Pharmaceuticals. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Equities

Equities by Sector

Sectors

Investment Strategy

Latest

Equity strategy and market outlook – April 2024

Equity strategy and market outlook – March 2024

Equity strategy and market outlook – February 2024

Thematics

Latest

Listed private equity – Performing a balancing act

ConsumerWatch – At least someone loves me

MediaWatch – Rinse and repeat

Audiovisual

Latest

Checkit – executive interview

International Public Partnerships – executive interview

Unlocking US capital: Strategies for non-US-listed businesses

About Edison

About Edison

Careers

SymBio Pharmaceuticals (TYO: 4582)

Latest Insights

SymBio Pharmaceuticals — The first whole quarter of internal SymBio sales

SymBio Pharmaceuticals — Treakisym approved for DLBCL

SymBio Pharmaceuticals — Now with commercial operations

SymBio Pharmaceuticals — Treakisym RTD approved

Sector

Share Price Performance

Financials

SymBio Pharmaceuticals — Treakisym has positive DLBCL results

SymBio Pharmaceuticals — Treakisym has positive DLBCL results

SymBio Pharmaceuticals — Guidance sinks on quality control issue

SymBio Pharmaceuticals — Looking forward to Treakisym Phase III data

SymBio Pharmaceuticals — Looking forward to Treakisym Phase III data

SymBio Pharmaceuticals — Preparing to establish own sales organization

SymBio Pharmaceuticals — Preparing to establish own sales organisation

SymBio Pharmaceuticals — Self-commercialization gains favor

SymBio Pharmaceuticals — Self-commercialisation gains favour

SymBio Pharmaceuticals — Licence agreement for IONSYS terminated

SymBio Pharmaceuticals — Licence agreement for IONSYS terminated

SymBio Pharmaceuticals — New formulations extend Treakisym patent life

SymBio Pharmaceuticals — Update 27 February 2017

SymBio Pharmaceuticals — Update 27 February 2017

SymBio Pharmaceuticals — Update 27 February 2017

SymBio Pharmaceuticals — Update 6 January 2017

SymBio Pharmaceuticals — Update 23 March 2016

SymBio Pharmaceuticals — Update 21 March 2016

SymBio Pharmaceuticals — Update 30 November 2015

SymBio Pharmaceuticals — Update 29 November 2015